Navigation Links
Michael L. Parks, MD, Elected to the American Academy of Orthopaedic Surgeons Board of Directors
Date:2/26/2009

LAS VEGAS, Feb. 26 /PRNewswire-USNewswire/ -- Orthopaedic surgeon Michael L. Parks, MD, was elected to the Board of Directors of the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/), at the 2009 Annual Meeting in Las Vegas. He will serve the Academy as Member-at-Large for the "under 45 year old" Board position.

Dr. Parks specializes in the reconstruction of arthritic conditions affecting the hip and knee. He is currently assistant attending orthopaedic surgeon at Hospital for Special Surgery and assistant professor of orthopaedic surgery at the Cornell Weill School of Medicine in New York.

After earning an undergraduate degree in Chemistry from Duke University in North Carolina, Dr. Parks graduated from the Medical University of South Carolina, in Charleston. Completing his internship in general and thoracic surgery, followed by an orthopaedic residency at Duke University Medical Center, Dr. Parks continued his training at Hospital for Special Surgery with a fellowship on the Hip and Knee Service.

"I am looking forward to the opportunity to serve on the Academy's Board of Directors," said Dr. Parks. "With the ever increasing demands from our aging population and decreasing resources, the Academy's role in advocacy and education becomes more important. It is my hope to bring the perspective of an urban practicing orthopaedist to the Board, while working to strengthen the reach of our organization."

As an Academy Fellow, Dr. Parks serves on the Board of Councilors and is past Chair of the Board of Councilors Bylaws Review Committee. He is also a member of the Leadership Development Committee. "Dr. Parks' ideas and perspectives are always well thought out, well expressed, and respectful of others who have differing opinions," said Thomas C. Barber, MD, Chair-Elect of the Academy's Board of Councilors.

Dr. Parks is an active member of the American Orthopaedic Association (AOA), the American Association of Hip and Knee Surgeons (AAHKS), and the J. Robert Gladden Orthopaedic Society. He is a guest reviewer for the Journal of Bone and Joint Surgery and is also the author of research papers and book chapters.

"With the constant changes evident in today's health care environment, it is essential that we as orthopaedic surgeons remain involved locally, in our individual medical centers and communities, as well as nationally to bolster our ability to perform our craft," notes Dr. Parks. "Only through our involvement will we advance ourselves and our ability to care for the patients whom we serve."

More about Dr. Parks

(http://www.hss.org/physicians_parks-michael.asp)

About AAOS

(http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735)

    For more information, contact:

    Catherine Dolf
    C (847) 894-9112
    O (847) 384-4034
    dolf@aaos.org

    Lauren L. Pearson
    C (224) 374-8610
    O (847) 384-4031
    lpearson@aaos.org




'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American TeleCare, Inc. (ATI) Appoints Michael A. Brodeur as Chief Financial Officer
2. Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain
3. Former Health & Human Services Secretary Michael Leavitt To Address Health Plan Member Retention Summit
4. Former Health & Human Services Secretary Michael Leavitt to Address Health Plan Member Retention Summit
5. Michael J. Fox Foundation Awards $2.5 Million for Parkinsons Drug Development Projects Led By Academic Investigators
6. Suzanne Somers Appears on CNBCs Conversations with Michael Eisner and Discusses NeoStems Adult Stem Cell Collection Program
7. KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
8. Michael Kincaid Named Executive Vice President, Chief Financial Officer and Treasurer of HVHC Inc.
9. NYC Mayor Michael R. Bloomberg Declares January 8th IBREA Brain Education Day
10. Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales
11. DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
Breaking Medicine Technology: